Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Investigators at Sun Yat-Sen University, Cancer Center publish new data on cancer gene therapy
February 24th, 2009
Scientists discuss in 'The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells' new findings in cancer gene therapy. According to a study from Guangzhou, People's Republic of China, "The c-Jun NH2-terminal kinase (JNK) pathway represents one subgroup of MAP kinases that are activated primarily by cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes." "Autophagy-related gene beclin 1 plays a key role in autophagosome formation. However, the relationships between activation of...
Source: Cancer Weekly (2009-02-24)
|
